FLCN gene-mutated renal cell neoplasms: Mother and daughter cases with a novel germline mutation

International Journal of Urology

Volumn 19, Issue 5, 2012, Pages 468-470

  Nagashima, Yoji ^a   Furuya, Mitsuko ^a   Gotohda, Hiroko ^b   Takagi, Seiji ^c   Hes, Ondrej ^f   Michal, Michal ^f   Grossmann, Petr ^f   Tanaka, Reiko ^d   Nakatani, Yukio ^d   Kuroda, Naoto ^e  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b Division of Pathology   (Japan)

^c JA Hokkaido Koseiren Kucchan Kosei Hospital   (Japan)

^d CHIBA UNIVERSITY   (Japan)

^e KOCHI RED CROSS HOSPITAL   (Japan)

^f CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Birt Hogg Dub syndrome; Chromophobe renal cell carcinoma; FCLN gene; Hybrid oncocytic chromophobe tumor; Mutation; Oncocytoma

Indexed keywords

ESTRONE;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; BIRT HOGG DUBE SYNDROME; CANCER CELL; CANCER SIZE; CASE REPORT; DNA DETERMINATION; EXON; FEMALE; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY HYBRID ONCOCYTE CHROMOPHOBE TUMOR; KIDNEY PARENCHYMA; KIDNEY TUMOR; NEPHRECTOMY; PNEUMATOCELE; PRIORITY JOURNAL;

AGED; AMINO ACID SEQUENCE; BIRT-HOGG-DUBE SYNDROME; CARCINOMA, RENAL CELL; FEMALE; GERM-LINE MUTATION; HUMANS; KIDNEY; KIDNEY NEOPLASMS; MIDDLE AGED; MUTATION; NUCLEAR FAMILY; PROTO-ONCOGENE PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 84860255080     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2011.02945.x     Document Type: Article

References (10)

1. Menko FH, van Steensel MA, Giraud S etal. Birt-Hogg-Dubé syndrome: diagnosis and management. Lancet Oncol. 2009; 10: 1199-206.
2. Pavlovich CP, Walther MM, Eyler RA etal. Renal tumors in the Birt-Hogg-Dubé syndrome. Am. J. Surg. Pathol. 2002; 26: 1542-52.
3. Nickerson ML, Warren MB, Toro JR etal. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome. Cancer Cell 2002; 2: 157-64.
4. Nagy A, Zoubakov D, Stupar Z, Kovacs G. Lack of mutation of the folliculin gene in sporadic chromophobe renal cell carcinoma and renal oncocytoma. Int. J. Cancer 2004; 109: 472-5.
5. Murakami T, Sano F, Huang Y etal. Identification and characterization of Birt-Hogg-Dubé associated renal carcinoma. J. Pathol. 2007; 211: 524-31.
6. Koga S, Furuya M, Takahashi Y etal. Lung cysts in Birt-Hogg-Dube syndrome: histopathological characteristics and aberrant sequencing repeats. Pathol. Int. 2009; 59: 720-8.
7. Khoo SK, Giraud S, Kahnoski K etal. Clinical and genetic studies of Birt-Hogg-Dubé syndrome. J. Med. Genet. 2002; 39: 906-12.
8. Merino MJ, Eccles DM, Linehan WM etal. Familial renal cell carcinoma. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. IARC Press, Lyon, 2004; 15-22.
9. Baba M, Furihata M, Hong SB etal. Kidney-targeted Birt-Hogg-Dubé gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys. J. Natl Cancer Inst. 2008; 100: 140-54.
10. Hasumi Y, Baba M, Ajima R etal. Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2. Proc. Natl. Acad. Sci. USA 2009; 106: 18722-7.